COVID-19对加拿大社区抗生素使用的影响:一项生态学研究
该生态学研究利用IQVIA的CompuScript数据库2014年11月至2020年10月加拿大社区零售药房抗生素配药数据,按年龄、性别、处方来源和大致适应证分层分析。校正季节性后,加拿大COVID-19疫情前8个月(2020年3月至10月)全国抗生素配药率较COVID-19前下降26.5%(从每1000居民平均50.4张降至37.0张处方)。作者指出需进一步研究观察到的下降对加拿大抗生素耐药性的影响和长期效应。
要点
- 加拿大COVID-19疫情前8个月社区抗生素配药率较疫情前下降26.5%(50.4降至37.0张/1000居民)。
- 2020年4月≤18岁男性配药率从43.7降至12.2张/1000居民(-72%),女性从46.8降至14.9张/1000居民(-68%)。
- 2020年5月≥65岁男性配药率从74.9降至48.8张/1000居民(-35%),女性从91.7降至61.3张/1000居民(-33%)。
核心结论
- 校正季节性后,加拿大COVID-19疫情前8个月全国抗生素配药率较COVID-19前下降26.5%(从每1000居民平均50.4张降至37.0张处方),而2015年至2019年抗生素消耗仅边际下降3%。
- 作者指出需进一步研究以了解观察到的抗生素使用下降对加拿大抗生素耐药性的影响和长期效应。
研究设计与样本
- 该生态学研究使用IQVIA的CompuScript数据库的全国抗生素配药数据,调查2014年11月至2020年10月加拿大社区零售药房的抗生素配药情况。
- 分析按年龄、性别、处方来源和大致适应证进行分层。
主要发现
- 校正季节性后,加拿大COVID-19疫情前8个月(2020年3月至10月)全国抗生素配药率较COVID-19前下降26.5%(从每1000居民平均50.4张降至37.0张处方)。
- 2020年4月,≤18岁男性配药率从每1000居民43.7张降至12.2张(-72%),女性从46.8张降至14.9张(-68%)。
- 2020年5月,≥65岁男性配药率从每1000居民74.9张降至48.8张(-35%),女性从91.7张降至61.3张(-33%)。
- 来自家庭医生的抗生素处方下降幅度大于外科医生和感染科医生。
- 2020年5月,呼吸道适应证抗生素处方率下降56%(从每1000居民29.2张降至12.8张),而尿路感染处方率从9.4张降至7.8张(-17%),皮肤和软组织感染处方率从6.4张降至5.2张(-19%)。
局限性
- 作者指出需进一步研究以了解观察到的抗生素使用下降对加拿大抗生素耐药性的影响和长期效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The COVID-19 pandemic has had an effect on the incidence of infectious diseases and medical care. This study aimed to describe the impact of the COVID-19 pandemic on community-level antibiotic use. METHODS: Using national antibiotic dispensing data from IQVIA's CompuScript database, this ecological study investigated antibiotic dispensing through community retail pharmacies in Canada from November 2014 to October 2020. Analyses were stratified by age, sex, prescription origin and approximate indication. RESULTS: Adjusting for seasonality, the national rate of antibiotic dispensing in Canada decreased by 26.5% (50.4 to 37.0 average prescriptions per 1000 inhabitants) during the first 8 months of the Canadian COVID-19 period (March to October 2020), compared with the pre-COVID-19 period. Prescribing rates in children ≤18 years decreased from 43.7 to 12.2 prescriptions per 1000 inhabitants in males (-72%) and from 46.8 to 14.9 prescriptions per 1000 inhabitants in females (-68%) in April 2020. Rates in adults ≥65 decreased from 74.9 to 48.8 prescriptions per 1000 inhabitants in males (-35%) and from 91.7 to 61.3 prescriptions per 1000 inhabitants in females (-33%) in May 2020. Antibiotic prescriptions from family physicians experienced a greater decrease than from surgeons and infectious disease physicians. Prescribing rates for antibiotics for respiratory indications decreased by 56% in May 2020 (29.2 to 12.8 prescriptions per 1000 inhabitants), compared with prescribing rates for urinary tract infections (9.4 to 7.8 prescriptions per 1000 inhabitants; -17%) and skin and soft tissue infections (6.4 to 5.2 prescriptions per 1000 inhabitants; -19%). DISCUSSION: The first 8 months of the COVID-19 pandemic reduced community antibiotic dispensing by 26.5% in Canada, compared with the marginal decrease of 3% in antibiotic consumption between 2015 and 2019. Further research is needed to understand the implications and long-term effects of the observed reductions on antibiotic use on antibiotic resistance in Canada.
引用
- Knight BD, Shurgold J, Smith G, et al. The impact of COVID-19 on community antibiotic use in Canada: an ecological study. Clin Microbiol Infect. 2021. PMID: 34757115. doi:10.1016/j.cmi.2021.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。